In preclinical models, Ptx3 deficiency was associated to higher susceptibility to chemical carcinogenesis (9), while in human prostate cancer PTX3 expression is progressively reduced in high-grade prostatic intraepithelial neoplasia and invasive tumor areas (35). This evidence concerns the gene PTX3 and prostate carcinoma.